KMT2A and acute myeloid leukemia: Similar effects in AML cell lines were also seen for the HDAC inhibitor I3 in AML cells with t(8; 21) translocation and MLL rearranged cell lines [179]; this study also described activation of the VEGF/MAPK (mitogen-activated protein kinase) signaling pathway.